erythromycin has been researched along with Hyperplasia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Gan, L; Huang, Z; Li, W; Liu, G; Qin, C; Wei, P; Zeng, T | 1 |
Yamaya, M | 1 |
Cho, YJ; Kim, EY; Park, YS; Shin, DH; Shin, JH; Song, HY; Yoon, HK | 1 |
1 review(s) available for erythromycin and Hyperplasia
Article | Year |
---|---|
[Effects of mucolytic agents and macrolides in the treatment of COPD].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antiviral Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Erythromycin; Expectorants; Goblet Cells; Humans; Hyperplasia; Macrolides; Mucins; Mucociliary Clearance; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Treatment Outcome | 2016 |
2 other study(ies) available for erythromycin and Hyperplasia
Article | Year |
---|---|
Protective effects of different anti‑inflammatory drugs on tracheal stenosis following injury and potential mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Budesonide; Collagen; Disease Models, Animal; Erythromycin; Granulation Tissue; Histone Deacetylase 2; Hyperplasia; Interleukin-8; Penicillins; Protective Agents; Rabbits; Trachea; Tracheal Stenosis; Transforming Growth Factor beta1; Up-Regulation; Vascular Endothelial Growth Factor A | 2021 |
The effectiveness of erythromycin in reducing stent-related tissue hyperplasia: an experimental study with a rat esophageal model.
Topics: Animals; Anti-Inflammatory Agents; Erythromycin; Esophagitis; Esophagus; Hyperplasia; Injections, Intraperitoneal; Male; Rats; Rats, Sprague-Dawley; Stents | 2012 |